PsiOxus Therapeutics Ltd.
Harnessing the power of evolution to develop oncolytic viruses
This article was originally published in Start Up
Executive Summary
Harnessing the power of Darwinian natural selection to find therapeutic oncolytic adenoviruses is one of the aims of the Oxford, UK-based start-up PsiOxus Therapeutics Ltd. Another is to develop the first therapies for the wasting syndromes cachexia and sarcopenia.